My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 124

    1.

    Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma.

    Erdag G, Schaefer JT, Smolkin ME, Deacon DH, Shea SM, Dengel LT, Patterson JW, Slingluff CL Jr.

    Cancer Res. 2012 Mar 1;72(5):1070-80. Epub 2012 Jan 19.

    PMID:
    22266112
    [PubMed - indexed for MEDLINE]

    Related citations

    2.

    Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.

    Pietra G, Manzini C, Rivara S, Vitale M, Cantoni C, Petretto A, Balsamo M, Conte R, Benelli R, Minghelli S, Solari N, Gualco M, Queirolo P, Moretta L, Mingari MC.

    Cancer Res. 2012 Mar 15;72(6):1407-15. Epub 2012 Jan 18.

    PMID:
    22258454
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    Metastasis suppressor NM23-H1 promotes repair of UV-induced DNA damage and suppresses UV-induced melanomagenesis.

    Jarrett SG, Novak M, Dabernat S, Daniel JY, Mellon I, Zhang Q, Harris N, Ciesielski MJ, Fenstermaker RA, Kovacic D, Slominski A, Kaetzel DM.

    Cancer Res. 2012 Jan 1;72(1):133-43. Epub 2011 Nov 11.

    PMID:
    22080566
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    Activated STAT5 promotes long-lived cytotoxic CD8+ T cells that induce regression of autochthonous melanoma.

    Grange M, Buferne M, Verdeil G, Leserman L, Schmitt-Verhulst AM, Auphan-Anezin N.

    Cancer Res. 2012 Jan 1;72(1):76-87. Epub 2011 Nov 7.

    PMID:
    22065720
    [PubMed - indexed for MEDLINE]

    Related citations

    5.

    Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity.

    Yi H, Guo C, Yu X, Gao P, Qian J, Zuo D, Manjili MH, Fisher PB, Subjeck JR, Wang XY.

    Cancer Res. 2011 Nov 1;71(21):6611-20. Epub 2011 Sep 13.

    PMID:
    21914786
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Shorter telomeres associate with a reduced risk of melanoma development.

    Nan H, Du M, De Vivo I, Manson JE, Liu S, McTiernan A, Curb JD, Lessin LS, Bonner MR, Guo Q, Qureshi AA, Hunter DJ, Han J.

    Cancer Res. 2011 Nov 1;71(21):6758-63. Epub 2011 Oct 25.

    PMID:
    22028319
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis.

    Zigler M, Kamiya T, Brantley EC, Villares GJ, Bar-Eli M.

    Cancer Res. 2011 Nov 1;71(21):6561-6. Epub 2011 Oct 18. Review.

    PMID:
    22009534
    [PubMed - indexed for MEDLINE]

    Related citations

    8.

    Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells.

    Nierkens S, den Brok MH, Garcia Z, Togher S, Wagenaars J, Wassink M, Boon L, Ruers TJ, Figdor CG, Schoenberger SP, Adema GJ, Janssen EM.

    Cancer Res. 2011 Oct 15;71(20):6428-37. Epub 2011 Jul 25.

    PMID:
    21788345
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines.

    Kreiter S, Diken M, Selmi A, Diekmann J, Attig S, Hüsemann Y, Koslowski M, Huber C, Türeci Ö, Sahin U.

    Cancer Res. 2011 Oct 1;71(19):6132-42. Epub 2011 Aug 4.

    PMID:
    21816907
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control.

    Hong M, Puaux AL, Huang C, Loumagne L, Tow C, Mackay C, Kato M, Prévost-Blondel A, Avril MF, Nardin A, Abastado JP.

    Cancer Res. 2011 Nov 15;71(22):6997-7009. Epub 2011 Sep 26.

    PMID:
    21948969
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression.

    Noman MZ, Janji B, Kaminska B, Van Moer K, Pierson S, Przanowski P, Buart S, Berchem G, Romero P, Mami-Chouaib F, Chouaib S.

    Cancer Res. 2011 Sep 15;71(18):5976-86. Epub 2011 Aug 2.

    PMID:
    21810913
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    TGF-β/SMAD/GLI2 signaling axis in cancer progression and metastasis.

    Javelaud D, Alexaki VI, Dennler S, Mohammad KS, Guise TA, Mauviel A.

    Cancer Res. 2011 Sep 1;71(17):5606-10. Epub 2011 Aug 23. Review.

    PMID:
    21862631
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    Chromogranin A restricts drug penetration and limits the ability of NGR-TNF to enhance chemotherapeutic efficacy.

    Dondossola E, Gasparri AM, Colombo B, Sacchi A, Curnis F, Corti A.

    Cancer Res. 2011 Sep 1;71(17):5881-90. Epub 2011 Jul 28.

    PMID:
    21799030
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    Potent antitumor immunity generated by a CD40-targeted adenoviral vaccine.

    Hangalapura BN, Oosterhoff D, de Groot J, Boon L, Tüting T, van den Eertwegh AJ, Gerritsen WR, van Beusechem VW, Pereboev A, Curiel DT, Scheper RJ, de Gruijl TD.

    Cancer Res. 2011 Sep 1;71(17):5827-37. Epub 2011 Jul 11.

    PMID:
    21747119
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    IL-18 induces PD-1-dependent immunosuppression in cancer.

    Terme M, Ullrich E, Aymeric L, Meinhardt K, Desbois M, Delahaye N, Viaud S, Ryffel B, Yagita H, Kaplanski G, Prévost-Blondel A, Kato M, Schultze JL, Tartour E, Kroemer G, Chaput N, Zitvogel L.

    Cancer Res. 2011 Aug 15;71(16):5393-9. Epub 2011 Jul 1.

    PMID:
    21724589
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    The ICOS/ICOSL pathway is required for optimal antitumor responses mediated by anti-CTLA-4 therapy.

    Fu T, He Q, Sharma P.

    Cancer Res. 2011 Aug 15;71(16):5445-54. Epub 2011 Jun 27.

    PMID:
    21708958
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Combinatorial treatments that overcome PDGFRβ-driven resistance of melanoma cells to V600EB-RAF inhibition.

    Shi H, Kong X, Ribas A, Lo RS.

    Cancer Res. 2011 Aug 1;71(15):5067-74.

    PMID:
    21803746
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers.

    Palaskas N, Larson SM, Schultz N, Komisopoulou E, Wong J, Rohle D, Campos C, Yannuzzi N, Osborne JR, Linkov I, Kastenhuber ER, Taschereau R, Plaisier SB, Tran C, Heguy A, Wu H, Sander C, Phelps ME, Brennan C, Port E, Huse JT, Graeber TG, Mellinghoff IK.

    Cancer Res. 2011 Aug 1;71(15):5164-74. Epub 2011 Jun 6.

    PMID:
    21646475
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    CD8+ T cells regulate bone tumor burden independent of osteoclast resorption.

    Zhang K, Kim S, Cremasco V, Hirbe AC, Collins L, Piwnica-Worms D, Novack DV, Weilbaecher K, Faccio R.

    Cancer Res. 2011 Jul 15;71(14):4799-808. Epub 2011 May 20. Erratum in: Cancer Res. 2012 Jan 15;72(2):568.

    PMID:
    21602433
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    GPR56 Regulates VEGF production and angiogenesis during melanoma progression.

    Yang L, Chen G, Mohanty S, Scott G, Fazal F, Rahman A, Begum S, Hynes RO, Xu L.

    Cancer Res. 2011 Aug 15;71(16):5558-68. Epub 2011 Jul 1.

    PMID:
    21724588
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk